Hedgehog Signaling: From Basic Biology to Cancer Therapy

被引:251
作者
Wu, Fujia [1 ,2 ]
Zhang, Yu [1 ]
Sun, Bo [1 ]
McMahon, Andrew P. [3 ]
Wang, Yu [1 ,2 ]
机构
[1] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[3] Univ Southern Calif, Eli & Edythe Broad CIRM Ctr Regenerat Med & Stem, WM Keck Sch Med, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90033 USA
基金
中国国家自然科学基金;
关键词
SMALL-MOLECULE INHIBITORS; PHASE-II TRIAL; VERATRUM-CALIFORNICUM DURAND; PATIENT PRESELECTION TOOL; STEROL-SENSING DOMAIN; BASAL-CELL CARCINOMAS; SONIC-HEDGEHOG; PATHWAY INHIBITOR; TRANSCRIPTION FACTOR; HUMAN HOMOLOG;
D O I
10.1016/j.chembiol.2017.02.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Hedgehog (HH) signaling pathway was discovered originally as a key pathway in embryonic patterning and development. Since its discovery, it has become increasingly clear that the HH pathway also plays important roles in a multitude of cancers. Therefore, HH signaling has emerged as a therapeutic target of interest for cancer therapy. In this review, we provide a brief overview of HH signaling and the key molecular players involved and offer an up-to-date summary of our current knowledge of endogenous and exogenous small molecules that modulate HH signaling. We discuss experiences and lessons learned from the decades-long efforts toward the development of cancer therapies targeting the HH pathway. Challenges to develop next-generation cancer therapies are highlighted.
引用
收藏
页码:252 / 280
页数:29
相关论文
共 234 条
[61]   Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study [J].
Gajjar, Amar ;
Stewart, Clinton F. ;
Ellison, David W. ;
Kaste, Sue ;
Kun, Larry E. ;
Packer, Roger J. ;
Goldman, Stewart ;
Chintagumpala, Murali ;
Wallace, Dana ;
Takebe, Naoko ;
Boyett, James M. ;
Gilbertson, Richard J. ;
Curran, Tom .
CLINICAL CANCER RESEARCH, 2013, 19 (22) :6305-6312
[62]   Hedgehog Signaling Is Dispensable for Adult Hematopoietic Stem Cell Function [J].
Gao, Jie ;
Graves, Stephanie ;
Koch, Ute ;
Liu, Suqing ;
Jankovic, Vladimir ;
Buonamici, Silvia ;
El Andaloussi, Abdeljabar ;
Nimer, Stephen D. ;
Kee, Barbara L. ;
Taichman, Russell ;
Radtke, Freddy ;
Aifantis, Iannis .
CELL STEM CELL, 2009, 4 (06) :548-558
[63]   Phosphoinositides Regulate Ciliary Protein Trafficking to Modulate Hedgehog Signaling [J].
Garcia-Gonzalo, Francesc R. ;
Phua, Siew Cheng ;
Roberson, Elle C. ;
Garcia, Galo, III ;
Abedin, Monika ;
Schurmans, Stephane ;
Inoue, Takanari ;
Reiter, Jeremy F. .
DEVELOPMENTAL CELL, 2015, 34 (04) :400-409
[64]   Preclinical characterization of BMS-833923 (XL139), a hedgehog (HH) pathway inhibitor in early clinical development [J].
Gendreau, Steven B. ;
Hawkins, Don ;
Ho, Ching-Ping ;
Lewin, Anne ;
Lin, Tara ;
Merchant, Akil ;
Rowley, R. Bruce ;
Wang, Qiuju ;
Matsui, William ;
Fargnoli, Joseph .
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
[65]  
Geoerger B, 2012, J CLIN ONCOL, V30
[66]   Subtypes of medulloblastoma have distinct developmental origins [J].
Gibson, Paul ;
Tong, Yiai ;
Robinson, Giles ;
Thompson, Margaret C. ;
Currle, D. Spencer ;
Eden, Christopher ;
Kranenburg, Tanya A. ;
Hogg, Twala ;
Poppleton, Helen ;
Martin, Julie ;
Finkelstein, David ;
Pounds, Stanley ;
Weiss, Aaron ;
Patay, Zoltan ;
Scoggins, Matthew ;
Ogg, Robert ;
Pei, Yanxin ;
Yang, Zeng-Jie ;
Brun, Sonja ;
Lee, Youngsoo ;
Zindy, Frederique ;
Lindsey, Janet C. ;
Taketo, Makoto M. ;
Boop, Frederick A. ;
Sanford, Robert A. ;
Gajjar, Amar ;
Clifford, Steven C. ;
Roussel, Martine F. ;
McKinnon, Peter J. ;
Gutmann, David H. ;
Ellison, David W. ;
Wechsler-Reya, Robert ;
Gilbertson, Richard J. .
NATURE, 2010, 468 (7327) :1095-1099
[67]   Phase I Dose-Escalation Trial of the Oral Investigational Hedgehog Signaling Pathway Inhibitor TAK-441 in Patients with Advanced Solid Tumors [J].
Goldman, Jonathan ;
Eckhardt, S. Gail ;
Borad, Mitesh J. ;
Curtis, Kelly K. ;
Hidalgo, Manuel ;
Calvo, Emiliano ;
Ryan, David P. ;
Wirth, Lori J. ;
Parikh, Asit ;
Partyka, James ;
Faessel, Helene ;
Gangolli, Esha ;
Stewart, Sally ;
Rosen, Lee S. ;
Bowles, Daniel W. .
CLINICAL CANCER RESEARCH, 2015, 21 (05) :1002-1009
[68]   Discovery, Molecular and Pharmacological Characterization of GSA-10, a Novel Small-Molecule Positive Modulator of Smoothened [J].
Gorojankina, Tatiana ;
Hoch, Lucile ;
Faure, Helene ;
Roudaut, Hermine ;
Traiffort, Elisabeth ;
Schoenfelder, Angele ;
Girard, Nicolas ;
Mann, Andre ;
Manetti, Fabrizio ;
Solinas, Antonio ;
Petricci, Elena ;
Taddei, Maurizio ;
Ruat, Martial .
MOLECULAR PHARMACOLOGY, 2013, 83 (05) :1020-1029
[69]   Pharmacokinetics of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors: the Role of Alpha-1-Acid Glycoprotein Binding [J].
Graham, Richard A. ;
Lum, Bert L. ;
Cheeti, Sravanthi ;
Jin, Yan Jin ;
Jorga, Karin ;
Von Hoff, Daniel D. ;
Rudin, Charles M. ;
Reddy, Josina C. ;
Low, Jennifer A. ;
LoRusso, Patricia M. .
CLINICAL CANCER RESEARCH, 2011, 17 (08) :2512-2520
[70]   Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome [J].
Hahn, H ;
Wicking, C ;
Zaphiropoulos, PG ;
Gailani, MR ;
Shanley, S ;
Chidambaram, A ;
Vorechovsky, I ;
Holmberg, E ;
Unden, AB ;
Gillies, S ;
Negus, K ;
Smyth, I ;
Pressman, C ;
Leffell, DJ ;
Gerrard, B ;
Goldstein, AM ;
Dean, M ;
Toftgard, R ;
ChenevixTrench, G ;
Wainwright, B ;
Bale, AE .
CELL, 1996, 85 (06) :841-851